Important note

This AI stock analysis for Lantheus is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!


Lantheus - AI Stock Analysis

Analysis generated November 15, 2024

Lantheus Holdings, Inc. is a prominent player in the healthcare sector, primarily specializing in diagnostic imaging agents and products. The company provides medical imaging solutions that help healthcare professionals diagnose and treat diseases more effectively. Lantheus’ portfolio includes nuclear imaging, ultrasound contrast agents, and other imaging products. Given its critical role in the healthcare diagnostics market, Lantheus is well-positioned to benefit from the ongoing advancements in medical technologies.

Fundamental Analysis

Revenue: The revenue for the last quarter stood at $379 million. While this represents a decrease of 3.77% compared to the previous quarter, it marks an increase of 20.29% compared to the same quarter last year. Year-over-year growth is a positive indicator, showing that the company is expanding its market share or improving its sales efficiency despite the QoQ decline.

Net Income: The net income for the last quarter was $131 million, a significant increase of 111.19% compared to the previous quarter. However, compared to the same quarter last year, net income decreased slightly by 0.65%. The strong QoQ growth is a positive sign, indicating potential improvements in cost management or operational efficiency.

EBITDA: The EBITDA for the last quarter was $189 million, which marks an increase of 105.85% compared to the previous quarter and an increase of 12.61% compared to the same quarter last year. This shows that the company is thriving in terms of profitability and cash flow generation.

P/E Ratio: The current P/E ratio is 13.25. This is within a normal range and suggests that the stock is neither overvalued nor undervalued at current earnings levels. A P/E ratio within the typical range adds a layer of stability and predictability to the stock’s valuation.

Technical Analysis

Stock Price: Today’s stock price is $77.38. This represents a decrease of 30.89% compared to a month ago, indicating short-term bearish sentiment. However, compared to a year ago, there is an increase of 13.54%, suggesting a long-term positive trend.

Stock Trend: The trend is currently bearish. This is inferred from the stock’s performance and short-term moving averages.

SMA10: The current SMA10 is 84.92, compared to the previous SMA10 of 88.68. This downward trend in SMA10 suggests potential continued bearish movement in the stock price.

RSI: The Relative Strength Index (RSI) is 68.3, indicating a neutral condition. The RSI is close to the overbought threshold of 70, hinting that the stock may become overbought soon if the upward trajectory resumes.

Alternative Data Analysis

Job Postings and Employee Sentiment: Lantheus has 77 open positions, up by 28% in the last couple of months, indicating a company preparing for growth and expansion. Despite this, employee sentiment remains neutral.

Customer Acquisition: The company’s website has attracted an estimated 59,000 visitors, up by 247% in recent months. This could signify higher customer interest and potential sales growth.

Customer Engagement: Lantheus has 530 followers on their Twitter page, an increase of 14% over the last couple of months, indicating a growing interest in the company among the social media audience.

AI Score: According to AltIndex’s AI prediction model, Lantheus has an AI score of 76, which is a bullish signal and a recommendation to buy.

Conclusion and Recommendation

Based on the comprehensive analysis above, Lantheus showcases positive long-term prospects despite recent short-term setbacks. The year-over-year growth in revenue and EBITDA points to the company’s ability to generate increased sales and maintain profitability. The significant increase in customer web traffic and job postings further corroborates the growth outlook.

However, the short-term technical indicators reflect a bearish trend, which might pose some risk to potential investors. Still, the P/E ratio suggests that the stock is reasonably valued, and the favorable AI score adds another layer of confidence in Lantheus’s long-term potential.

Recommendation: Considering the fundamental strength, modest valuation, and encouraging alternative data metrics, Lantheus stock appears to be a solid buy for long-term investors. However, due to the short-term bearish trend, cautious investors may want to wait for a reversal signal before taking a position.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.